|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Alexion_Pharmaceuticals
|
|
gptkbp:acquisitionYear
|
2021
|
|
gptkbp:awarded
|
gptkb:Queen's_Award_for_Enterprise
|
|
gptkbp:CEO
|
gptkb:Pascal_Soriot
|
|
gptkbp:collaboratedWith
|
gptkb:University_of_Oxford
|
|
gptkbp:competitor
|
gptkb:Pfizer
gptkb:Eli_Lilly_and_Company
gptkb:Johnson_&_Johnson
gptkb:Merck_&_Co.
gptkb:Sanofi
gptkb:Novartis
gptkb:Roche
gptkb:Bristol_Myers_Squibb
GlaxoSmithKline
|
|
gptkbp:countryOfOrigin
|
gptkb:United_Kingdom
|
|
gptkbp:developedBy
|
gptkb:COVID-19_vaccine_(Vaxzevria)
|
|
gptkbp:diversityInitiatives
|
Inclusion & Diversity strategy
|
|
gptkbp:dividendPaying
|
paid biannually
|
|
gptkbp:environmentalImpact
|
gptkb:Ambition_Zero_Carbon
|
|
gptkbp:focusArea
|
immunology
oncology
rare diseases
cardiovascular
respiratory
|
|
gptkbp:foundedBy
|
merger of Astra AB and Zeneca Group
|
|
gptkbp:foundedIn
|
1999
|
|
gptkbp:hasResearchCenter
|
gptkb:Cambridge_Biomedical_Campus
gptkb:Gothenburg,_Sweden
gptkb:Gaithersburg,_Maryland,_USA
|
|
gptkbp:headquartersLocation
|
gptkb:Cambridge,_United_Kingdom
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
AstraZeneca
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:ISIN
|
GB0009895292
|
|
gptkbp:legalForm
|
gptkb:public_company
|
|
gptkbp:listedOn
|
gptkb:London_Stock_Exchange
gptkb:NASDAQ
|
|
gptkbp:marketedIn
|
over 100 countries
|
|
gptkbp:memberOf
|
gptkb:FTSE_100_Index
|
|
gptkbp:netIncome
|
$5.5 billion (2023)
|
|
gptkbp:numberOfEmployees
|
over 80,000
|
|
gptkbp:officialWebsite
|
https://www.astrazeneca.com/
|
|
gptkbp:parentCompany
|
none
|
|
gptkbp:product
|
gptkb:Brilinta
gptkb:Calquence
gptkb:Crestor
gptkb:Farxiga
gptkb:Fasenra
gptkb:Imfinzi
gptkb:Lynparza
gptkb:Symbicort
gptkb:Tagrisso
|
|
gptkbp:revenue
|
$44.35 billion (2023)
|
|
gptkbp:stockExchange
|
gptkb:London_Stock_Exchange
gptkb:NASDAQ
|
|
gptkbp:stockSymbol
|
AZN
|
|
gptkbp:subsidiary
|
gptkb:MedImmune
gptkb:Alexion_Pharmaceuticals
gptkb:AstraZeneca_AB
gptkb:AstraZeneca_Pharmaceuticals_LP
|
|
gptkbp:sustainabilityReport
|
published annually
|
|
gptkbp:bfsParent
|
gptkb:COVID-19
|
|
gptkbp:bfsLayer
|
4
|